CONMED Statistics
Total Valuation
CONMED has a market cap or net worth of $2.31 billion. The enterprise value is $3.26 billion.
| Market Cap | 2.31B |
| Enterprise Value | 3.26B |
Important Dates
The last earnings date was Wednesday, April 24, 2024, after market close.
| Earnings Date | Apr 24, 2024 |
| Ex-Dividend Date | Mar 14, 2024 |
Share Statistics
CONMED has 30.80 million shares outstanding. The number of shares has increased by 0.88% in one year.
| Shares Outstanding | 30.80M |
| Shares Change (YoY) | +0.88% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 117.56% |
| Float | 30.53M |
Valuation Ratios
The trailing PE ratio is 28.63 and the forward PE ratio is 15.96. CONMED's PEG ratio is 5.29.
| PE Ratio | 28.63 |
| Forward PE | 15.96 |
| PS Ratio | 1.82 |
| Forward PS | 1.65 |
| PB Ratio | 2.69 |
| P/FCF Ratio | 16.26 |
| PEG Ratio | 5.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.48, with an EV/FCF ratio of 23.03.
| EV / Earnings | 39.57 |
| EV / Sales | 2.58 |
| EV / EBITDA | 20.48 |
| EV / EBIT | 22.80 |
| EV / FCF | 23.03 |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 1.16.
| Current Ratio | 2.18 |
| Quick Ratio | 0.94 |
| Debt / Equity | 1.16 |
| Debt / EBITDA | 6.23 |
| Debt / FCF | 7.00 |
| Interest Coverage | 3.65 |
Financial Efficiency
Return on equity (ROE) is 10.10% and return on invested capital (ROIC) is 6.14%.
| Return on Equity (ROE) | 10.10% |
| Return on Assets (ROA) | 3.60% |
| Return on Capital (ROIC) | 6.14% |
| Revenue Per Employee | $315,387 |
| Profits Per Employee | $20,587 |
| Employee Count | 4,000 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.73 |
Taxes
In the past 12 months, CONMED has paid $21.46 million in taxes.
| Income Tax | 21.46M |
| Effective Tax Rate | 20.67% |
Stock Price Statistics
The stock price has decreased by -37.10% in the last 52 weeks. The beta is 1.37, so CONMED's price volatility has been higher than the market average.
| Beta (1Y) | 1.37 |
| 52-Week Price Change | -37.10% |
| 50-Day Moving Average | 74.99 |
| 200-Day Moving Average | 94.69 |
| Relative Strength Index (RSI) | 55.07 |
| Average Volume (30 Days) | 529,432 |
Short Selling Information
The latest short interest is 846,967, so 2.75% of the outstanding shares have been sold short.
| Short Interest | 846,967 |
| Short Previous Month | 1.02M |
| Short % of Shares Out | 2.75% |
| Short % of Float | 2.77% |
| Short Ratio (days to cover) | 5.49 |
Income Statement
In the last 12 months, CONMED had revenue of $1.26 billion and earned $82.35 million in profits. Earnings per share was $2.61.
| Revenue | 1.26B |
| Gross Profit | 692.89M |
| Operating Income | 142.92M |
| Pretax Income | 103.80M |
| Net Income | 82.35M |
| EBITDA | 159.11M |
| EBIT | 142.92M |
| Earnings Per Share (EPS) | $2.61 |
Balance Sheet
The company has $33.86 million in cash and $990.80 million in debt, giving a net cash position of -$956.95 million or -$31.07 per share.
| Cash & Cash Equivalents | 33.86M |
| Total Debt | 990.80M |
| Net Cash | -956.95M |
| Net Cash Per Share | -$31.07 |
| Equity / Book Value | 854.66M |
| Book Value Per Share | 27.75 |
| Working Capital | 344.32M |
Cash Flow
In the last 12 months, operating cash flow was $158.32 million and capital expenditures -$16.81 million, giving a free cash flow of $141.50 million.
| Operating Cash Flow | 158.32M |
| Capital Expenditures | -16.81M |
| Free Cash Flow | 141.50M |
| FCF Per Share | $4.60 |
Margins
Gross margin is 54.92%, with operating and profit margins of 11.33% and 6.53%.
| Gross Margin | 54.92% |
| Operating Margin | 11.33% |
| Pretax Margin | 8.23% |
| Profit Margin | 6.53% |
| EBITDA Margin | 12.61% |
| EBIT Margin | 11.33% |
| FCF Margin | 11.22% |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 1.07%.
| Dividend Per Share | $0.80 |
| Dividend Yield | 1.07% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 30.65% |
| Buyback Yield | -0.88% |
| Shareholder Yield | 0.19% |
| Earnings Yield | 3.58% |
| FCF Yield | 6.15% |
Analyst Forecast
The average price target for CONMED is $106.63, which is 42.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $106.63 |
| Price Target Difference | 42.12% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 8.34% |
| EPS Growth Forecast (5Y) | 39.07% |
Stock Splits
The last stock split was on September 10, 2001. It was a forward split with a ratio of 3:2.
| Last Split Date | Sep 10, 2001 |
| Split Type | Forward |
| Split Ratio | 3:2 |
Scores
CONMED has an Altman Z-Score of 2.16 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.16 |
| Piotroski F-Score | 8 |